Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Takeda to sell portfolio of select drugs for $660 million

Written by: | no-reply@reuters.com | Dated: Tuesday, November 5th, 2019

 

Nov 5 (Reuters) – Takeda Pharmaceutical Co Ltd said on Tuesday it would sell some of its over-the-counter and prescription drugs to Germany’s STADA Arzneimittel AG for a total value of $660 million.

The portfolio includes drugs sold exclusively in Russia, Georgia and a number of countries from within the Commonwealth of Independent States, the company said.

STADA will acquire the rights, title, and interest to the products in the portfolio exclusive to these countries, Takeda added.

 

(Reporting by Rishika Chatterjee in Bengaluru; Editing by Anil D’Silva)

 

Reuters source:

https://www.reuters.com/article/takeda-pharma-divestiture-stada-arzneimi/takeda-to-sell-portfolio-of-select-drugs-for-660-million-idUSL3N27L23G

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!

Subscribe

Ad Right Bottom